NSW’s healthcare and life sciences industries are one of the most sophisticated and largest across Australia and present vast international trade potential. Hear from NSW’s representatives from Japan and Korea, China, Middle East, the US and Southeast Asia to learn about how you can tap into international opportunities, as well as about NSW Government’s export programs in the key markets.
The NSW Government recently released the NSW Trade & Investment Strategy 2035 that emphasises its focus on the NSW healthcare and life sciences sector – which added $60 billion in value to the NSW economy in 2024.
NSW’s health ecosystem is supported by strong educational institutions and research and dedicated public investment into precincts such as the Westmead Health Precinct. The life sciences and healthcare sector encompass industries involved in the research, development, manufacturing and delivery of products and services related to human health and wellbeing. NSW is home to the largest medical device ecosystem in Australia and accounts for 37% of Australia’s medical device revenue, as well as a global reputation for clinical trials and advanced therapeutics.
• Yoojin Kim, NSW Trade & Investment Director – Seoul
• Alia Jaafar, NSW Trade & investment Director – Malaysia
• Moin Anwar, NSW Trade & Investment Commissioner – Middle East
• Shupei Chen, NSW Trade & Investment Director – Hong Kong
• Shaun McAlpine, NSW Trade & Investment Director – San Francisco
• Daniel Meninelli, NSW Trade & Investment Director – New York
• Hanh Hoang, Senior Export Adviser, Investment NSW
